MMP9 and breast cancer: In mouse models of breast cancer bone metastases established by injection of human MDA-MB-231 breast cancer cells, expression of osteolytic factors (RANKL, Cathepsin-K, and MMP9) was higher in ovariectomized (OVX) mice mimicking the postmenopausal bone microenvironment, compared with sham operation.